Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 672.00 | |
500 mg | In stock | $ 1,430.00 |
Description | DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research. |
In vitro |
DHODH-IN-23 (72 h) inhibits proliferation of acute myeloid leukemia cells.[1] DHODH-IN-23 (0.1-3 μM; 72 h) induces the expression of CDllb in THP-1 cells.[1] |
In vivo | DHODH-IN-23 (30 mg/kg; oral; twice daily for 21 days) exhibits anti-tumor activity in the MV411 xenograft mouse model.[1] |
Molecular Weight | 441.88 |
Formula | C24H21ClFNO4 |
CAS No. | 1346705-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 112.5 mg/mL (254.6 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DHODH-IN-23 1346705-53-0 Metabolism Dehydrogenase inhibitor inhibit